Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
2015 DEPARTMENT OF MEDICINE RESEARCH DAY Title of Poster: Unlabeled thyroid hormone content of nonprescription U.S. weight loss products Presenter: Angela M. Leung, MD, MSc Division: Division of Endocrinology ☒Faculty ☐Fellow ☐Resident ☐Post-doc Research Fellow ☐Graduate Student ☐ Medical Student ☐Other Principal Investigator/Mentor: Angela M. Leung, M.D. M.W. Yeh, C.M. Rhee Co-Investigators: C. D. Seger, X. He, L.E. Braverman, Thematic Poster Category: Nutrition, Digestion and Metabolism Abstract Background: The U.S. Food and Drug Administration requires manufacturers of over-the-counter (OTC) supplements to ensure the safety of their products, including increasingly popular nonprescription weight loss aids. However, exogenous thyroid hormone, a medication prescribed to individuals with hypothyroidism that, in excess, may result in thyrotoxicosis, has been found in OTC supplements marketed for “thyroid support.” We hypothesize that OTC weight loss supplements also contain measurable quantities of thyroid hormone (thyroxine (T4) and/or triiodothyronine (T3)) that may be clinically significant. Methods: Twenty-nine popular OTC weight loss supplements were measured for T4 and T3 content by high performance liquid chromatography. Each reported value is the mean of duplicate measurements, all of which differed by <15%. Results: Nine (31%) of 29 products contained thyroid hormone. Five products (17%) contained only T3, four (14%) contained both T4 and T3, and none contained only T4. Of the nine products containing thyroid hormone, mean T4 content was 20.2±9.0 [SD] µg/day (n=4; range 9.6-29.6), and mean T3 content was 22.4±21 [SD] µg/day (n=9; range 2.8-66.6) based on manufacturers’ recommended daily dosing. Conclusion: Nearly one-third of sampled OTC U.S. weight loss products contain unlabeled thyroid hormone in doses that may result in clinically significant thyrotoxicosis. Increased regulation is needed to ensure the safety of consumers ingesting OTC weight loss products.